Pediatric surgeonĀ
Michael R. Harrison, MD and UC Berkeley engineerĀ
Phillip Messersmith, PhD are collaborating on an NIH-Funded research project toĀ improve glues used in fetal surgery procedures, notably those used to treat
twin-to-twin transfusion syndrome. Dr. Harrision, widely acknolwedged as the "father of fetal surgery", is Director Emeritus of the Fetal Treatment CenterĀ and leads the research of theĀ
Harrison Lab.Ā The full story was recently reported in UC Berkeley News.
Our doctors, nurses, and staff come from all walks of life with incredible backgrounds and life experiences. What leads them to the path of their chosen profession? We asked our staff to tell us what makes them passionate about the good work they do day in and day out at our medical centers. These are their stories.
Our doctors, nurses, and staff come from all walks of life with incredible backgrounds and life experiences. What leads them to the path of their chosen profession? We asked our staff to tell us what makes them passionate about the good work they do day in and day out at our medical centers. These are their stories.
Our doctors, nurses, and staff come from all walks of life with incredible backgrounds and life experiences. What leads them to the path of their chosen profession? We asked our staff to tell us what makes them passionate about the good work they do day in and day out at our medical centers. These are their stories.
Article in this week's Science Magazine_:_ Researchers are designing the first clinical trials of stem cell treatments for fetuses afflicted with rare bone and blood diseases. The trials, still being planned, involve arguably the trickiest patient population there is: pregnant women and their fetuses. And although researchers once thought that the fetal immune system would readily accept foreign cells, they now know that it is not that simple. But some fetuses have already been treated on an ad hoc basis, with encouraging results. After decades of hopes raised and dashed, pediatricians, immunologists, and others are cautiously hopeful that new biological insights and a push for treatment from parents-to-be could turn the tide for prenatal stem cell therapy.
Our doctors, nurses, and staff come from all walks of life with incredible backgrounds and life experiences. What leads them to the path of their chosen profession? We asked our staff to tell us what makes them passionate about the good work they do day in and day out at our medical centers. These are their stories.
Our doctors, nurses, and staff come from all walks of life with incredible backgrounds and life experiences. What leads them to the path of their chosen profession? We asked our staff to tell us what makes them passionate about the good work they do day in and day out at our medical centers. These are their stories.
The Fetal Treatment Center (FTC) has just launched a new mobile app, now available for download in the Apple app store and the Google Play for Android devices.
The Center for Maternal-Fetal Precision Medicine aims to integrate resources and talent between scientists and clinicians to accelerate research and clinical trials of fetal and neonatal interventions, create stronger bridges between basic research and clinical applications, and improve maternal, fetal and neonatal care.
Through advances in education and ultrasound technology, it is growing increasingly more common to have heart disease detected before birth. In some fetuses, intervention for the defect before birth might lead to better outcome later in life. Such fetal cardiac interventions are only performed in a few specialized centers throughout the world.